17,261 trials
HIV Infections
Primary: Part 1: Maximum Change From Baseline in Plasma Human Immunodeficiency Virus-1 (HIV-1) Ribonucleic Acid (RNA) at Day 11 — -8605.8; -100719.8; -3406.5 Copies per milliliter
Prostate Cancer
Primary: Decline in Serum PSA — 4; 10 participants
Familial Partial Lipodystrophy
Primary: Percent Change From Baseline in Fasting Triglycerides Levels at End of the Treatment (Week 27) — -59.9 percent change
Stage III Non-small Cell Lung Cancer
Primary: Disease-Control Rate — 89 Participants
Pancreatic Cancer
Primary: The Median Survival Time Will be Determined. — 12.8; 14.9 months
Hematologic Malignancies
Primary: Number of Nucleated Cells Collected Within the Apheresis Products — 5.7; 3.8 cells x10e10
Post-menopausal Vasomotor Symptoms
Primary: Maximum Observed Plasma Concentration (Cmax) of BAY3427080 — 502.62; 731.69; 911.48; 1576.01 ng/mL
Atopic Dermatitis
Primary: Number of Investigator's Global Assessment (IGA) Responders at Day 29 Following Treatment With ASB17061 Capsules or Placebo in Adults With Atopic Dermatitis — 20; 21…
Propionic Acidemia, Type I and/or Type II · Methylmalonic Acidemia · Carbamoyl-Phosphate Synthase I Deficiency Disease
Primary: Time to the Primary Outcome (Earlier of Ammonia <50 µmol/L or Hospital Discharge) — 1.37; 0.79 Hazard Ratio
Cardiac Arrest
Primary: Coenzyme Q10 Plasma Levels — 185; 207; 113; 441 ng/mL
Respiratory Tract Infection
Primary: Percentage of Participants Achieving Anti-Tetanus Toxoid (TTd) Antibody Concentrations of Greater Than or Equal to (>=) 0.1 International Units Per Milliliter (IU/mL) at…
Aplastic Anemia
Primary: Proportion of Subjects Achieving a Platelet Response at Week 9 — 0; 0; 3; 7 Participants
Myocardial Ischemia
Primary: Heme Oxygenase-1 (HO-1) Messenger Ribonucleic Acid (mRNA) Levels (Atrial Tissue) — 392.7; 229.8; 10.8 arbitrary units — p==0.001
Bone Marrow Transplant Infection · Infection in Marrow Transplant Recipients · Respiratory Syncytial Virus Infections
Primary: Percentage of Participants With Progression to Lower Respiratory Tract Infection (LRI) — 8; 30; 10 percentage of participants
Depression
Primary: Whole Brain Total Distribution Volume (VT) - Baseline — 8.2 mL x cm^3